Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New tablet device aims to lighten caregiver load in dementia

NCT ID NCT04308512

First seen Nov 06, 2025 · Last updated Jun 21, 2026 · Updated 36 times

Summary

This study tested a home device called Care4AD (Nili) designed to help caregivers coordinate daily activities for people with Alzheimer's or related dementia. The device provided reminders for tasks, social engagement, and medication. Researchers measured changes in caregiver burden and stress over 3 months in 33 caregiver-patient pairs. The goal was to see if the device could make caregiving easier and improve quality of life.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DEMENTIA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Baylor College of Medicine

    Houston, Texas, 77030, United States

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Nili device (interactive tablet with reminders and activities)

What this could lead to

If successful, this device could provide a practical tool to ease caregiver burden and improve daily life for people with dementia.

What could go wrong

This was a small, short-term study (33 participants, 3 months) with no blinding, so results may not apply widely or last long-term.

Conditions

The condition(s) this trial relates to.

Alzheimer disease dementia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.